BACKGROUND: Cone-beam CT (CBCT) scans are typically acquired daily for positioning verification of non-small cell lung cancer (NSCLC) patients. Quantitative information, derived using radiomics, can potentially contribute to (early) treatment adaptation. The aims of this study were to (1) describe and investigate a methodology for feature selection of a longitudinal radiomics approach (2) investigate which time-point during treatment is potentially useful for early treatment response assessment. MATERIAL AND METHODS: For 90 NSCLC patients CBCT scans of the first two fractions of treatment (considered as 'test-retest' scans) were analyzed, as well as weekly CBCT images. One hundred and sixteen radiomic features were extracted from the GTV of all scans and subsequently absolute and relative differences were calculated between weekly CBCT images and the CBCT of the first fraction. Test-retest scans were used to determine the smallest detectable change (C = 1.96 * SD) allowing for feature selection by choosing a minimum number of patients for which a feature should change more than 'C' to be considered as relevant. Analysis of which features change at which moment during treatment was used to investigate which time-point is potentially relevant to extract longitudinal radiomics information for early treatment response assessment. RESULTS: A total of six absolute delta features changed for at least ten patients at week 2 of treatment and increased to 61 at week 3, 79 at week 4 and 85 at week 5. There was 93% overlap between features selected at week 3 and the other weeks. CONCLUSIONS: This study describes a feature selection methodology for longitudinal radiomics that is able to select reproducible delta radiomics features that are informative due to their change during treatment, which can potentially be used for treatment decisions concerning adaptive radiotherapy. Nonetheless, the prognostic value of the selected delta radiomic features should be investigated in future studies.
BACKGROUND: Cone-beam CT (CBCT) scans are typically acquired daily for positioning verification of non-small cell lung cancer (NSCLC) patients. Quantitative information, derived using radiomics, can potentially contribute to (early) treatment adaptation. The aims of this study were to (1) describe and investigate a methodology for feature selection of a longitudinal radiomics approach (2) investigate which time-point during treatment is potentially useful for early treatment response assessment. MATERIAL AND METHODS: For 90 NSCLCpatients CBCT scans of the first two fractions of treatment (considered as 'test-retest' scans) were analyzed, as well as weekly CBCT images. One hundred and sixteen radiomic features were extracted from the GTV of all scans and subsequently absolute and relative differences were calculated between weekly CBCT images and the CBCT of the first fraction. Test-retest scans were used to determine the smallest detectable change (C = 1.96 * SD) allowing for feature selection by choosing a minimum number of patients for which a feature should change more than 'C' to be considered as relevant. Analysis of which features change at which moment during treatment was used to investigate which time-point is potentially relevant to extract longitudinal radiomics information for early treatment response assessment. RESULTS: A total of six absolute delta features changed for at least ten patients at week 2 of treatment and increased to 61 at week 3, 79 at week 4 and 85 at week 5. There was 93% overlap between features selected at week 3 and the other weeks. CONCLUSIONS: This study describes a feature selection methodology for longitudinal radiomics that is able to select reproducible delta radiomics features that are informative due to their change during treatment, which can potentially be used for treatment decisions concerning adaptive radiotherapy. Nonetheless, the prognostic value of the selected delta radiomic features should be investigated in future studies.
Authors: Howard E Morgan; Kai Wang; Michael Dohopolski; Xiao Liang; Michael R Folkert; David J Sher; Jing Wang Journal: Quant Imaging Med Surg Date: 2021-12
Authors: Nimu Yuan; Brandon Dyer; Shyam Rao; Quan Chen; Stanley Benedict; Lu Shang; Yan Kang; Jinyi Qi; Yi Rong Journal: Phys Med Biol Date: 2020-01-27 Impact factor: 3.609
Authors: Ana Barragán-Montero; Umair Javaid; Gilmer Valdés; Dan Nguyen; Paul Desbordes; Benoit Macq; Siri Willems; Liesbeth Vandewinckele; Mats Holmström; Fredrik Löfman; Steven Michiels; Kevin Souris; Edmond Sterpin; John A Lee Journal: Phys Med Date: 2021-05-09 Impact factor: 2.685
Authors: Liting Shi; Yaoyao He; Zilong Yuan; Stanley Benedict; Richard Valicenti; Jianfeng Qiu; Yi Rong Journal: Technol Cancer Res Treat Date: 2018-01-01
Authors: Jurgen Peerlings; Henry C Woodruff; Jessica M Winfield; Abdalla Ibrahim; Bernard E Van Beers; Arend Heerschap; Alan Jackson; Joachim E Wildberger; Felix M Mottaghy; Nandita M DeSouza; Philippe Lambin Journal: Sci Rep Date: 2019-03-18 Impact factor: 4.379
Authors: Janna E van Timmeren; Wouter van Elmpt; Ralph T H Leijenaar; Bart Reymen; René Monshouwer; Johan Bussink; Leen Paelinck; Evelien Bogaert; Carlos De Wagter; Elamin Elhaseen; Yolande Lievens; Olfred Hansen; Carsten Brink; Philippe Lambin Journal: Radiother Oncol Date: 2019-04-11 Impact factor: 6.280
Authors: Michele Avanzo; Lise Wei; Joseph Stancanello; Martin Vallières; Arvind Rao; Olivier Morin; Sarah A Mattonen; Issam El Naqa Journal: Med Phys Date: 2020-06 Impact factor: 4.071